Enfusion, Inc. Annual Cost of Revenue in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Enfusion, Inc. quarterly/annual Cost of Revenue history and growth rate from 2019 to 2023.
  • Enfusion, Inc. Cost of Revenue for the quarter ending September 30, 2024 was $16.3M, a 12.6% increase year-over-year.
  • Enfusion, Inc. Cost of Revenue for the twelve months ending September 30, 2024 was $64.1M, a 15.9% increase year-over-year.
  • Enfusion, Inc. annual Cost of Revenue for 2023 was $57.6M, a 22.4% increase from 2022.
  • Enfusion, Inc. annual Cost of Revenue for 2022 was $47.1M, a 47.9% increase from 2021.
  • Enfusion, Inc. annual Cost of Revenue for 2021 was $31.8M, a 49.1% increase from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $57.6M +$10.5M +22.4% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-12
2022 $47.1M +$15.3M +47.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-12
2021 $31.8M +$10.5M +49.1% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-12
2020 $21.4M +$4.4M +25.9% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-10
2019 $17M Jan 1, 2019 Dec 31, 2019 10-K 2022-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.